The U.S. Food and Drug Administration has tapped researchers at Johns Hopkins University and the Palo Alto Medical Foundation Research Institute for a two-year study that will analyze factors that determine underuse of generic drugs.
The study, Effect of Therapeutic Class on Generic Drug Substitutions, will analyze drug use in the U.S. by therapeutic class and create predictors to help determine when generic or brand-name medications are more likely to be used by patients. The research will also make use of patient-reported concerns about generic drugs, by therapeutic class, to identify reasons patients might ask their doctors to prescribe generic drugs. It also will develop a method for prioritizing drug classes that would benefit from generic drug development.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access